Welcome to our dedicated page for Lumexa Imaging Holdings SEC filings (Ticker: LMRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Lumexa Imaging Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Lumexa Imaging Holdings's regulatory disclosures and financial reporting.
Lumexa Imaging Holdings, Inc. director reports beneficial ownership of a stock option covering 22,222 shares of common stock at an exercise price of $18.5 per share, expiring on 12/10/2035.
The option vests in five substantially equal annual installments starting from a vesting commencement date of March 1, 2025, and each installment requires the director to continue serving with the company. The option is held directly.
Lumexa Imaging Holdings, Inc. filed an initial statement of beneficial ownership for Welsh, Carson, Anderson & Stowe–affiliated entities that are identified as both directors and 10% owners. These reporting persons disclose indirect holdings of Lumexa Imaging common stock through Common Units of Lumexa Imaging Equity Holdco, LLC (Holdings LLC), where each nine Common Units represent the right to acquire one share of common stock held by Holdings LLC.
The filing lists multiple blocks of common stock underlying these derivative securities, including 17,646,994 shares attributable to Welsh, Carson, Anderson & Stowe XII, L.P., 3,219,023 shares for Welsh, Carson, Anderson & Stowe XII Cayman, L.P., and 3,267,506 shares for WCAS Co-Invest Holdco, L.P. After Lumexa Imaging’s initial public offering and a 180-day lock-up period, Holdings LLC may distribute its common stock pro rata to remaining equity holders, at which time these indirect interests may be settled into Lumexa Imaging shares in connection with such a distribution.